BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 15480901)

  • 21. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study.
    Frimat L; Hestin D; Aymard B; Mayeux D; Renoult E; Kessler M
    Nephrol Dial Transplant; 1996 Jun; 11(6):1043-7. PubMed ID: 8671966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
    Kanno Y; Okada H; Saruta T; Suzuki H
    Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinuria and renal function in relation to renal morphology. A clinicopathological study of IgA nephropathy at the time of kidney biopsy.
    Widstam-Attorps U; Berg U; Bohman SO; Lefvert AK
    Clin Nephrol; 1992 Nov; 38(5):245-53. PubMed ID: 1451337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
    J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS; Kim BS; Shin YS; Yoon HE; Song JC; Choi BS; Park CW; Yang CW; Kim YS; Bang BK
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK; Leung CB; Chow KM; Cheng YL; Fung SK; Mak SK; Tang AW; Wong TY; Yung CY; Yung JC; Yu AW; Szeto CC;
    Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Amemiya N; Ochi A; Tsuruta Y; Shimizu A; Itabashi M; Takei T; Uchida K; Nitta K
    Am J Nephrol; 2011; 34(3):233-40. PubMed ID: 21778707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of steroid therapy in different stages of membranous nephropathy.
    Fuiano G; Stanziale P; Balletta M; Sepe V; Marinelli G; Comi N; Esposito A; Andreucci VE
    Nephrol Dial Transplant; 1989; 4(12):1022-9. PubMed ID: 2517322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of intensive therapy combined with tonsillectomy in patients with IgA nephropathy.
    Hotta O; Taguma Y; Yoshizawa N; Oda T; Nishiyama J; Yusa N; Chiba S; Horigome I; Sudo K; Tomioka S
    Acta Otolaryngol Suppl; 1996; 523():165-8. PubMed ID: 9082770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of methylprednisolone pulse therapy on progressive IgA nephropathy].
    Yoshimura M; Kida H; Saito Y; Takaeda M; Sugioka G
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):761-8. PubMed ID: 1770636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria.
    Kawaguchi T; Ieiri N; Yamazaki S; Hayashino Y; Gillespie B; Miyazaki M; Taguma Y; Fukuhara S; Hotta O
    Nephrology (Carlton); 2010 Feb; 15(1):116-23. PubMed ID: 20377779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgA-mesangial nephropathy (Berger's disease) with rapid decline in renal function.
    D'Amico G; Ferrario F; Colasanti G; Ragni A; Bestetti Bosisio M
    Clin Nephrol; 1981 Nov; 16(5):251-7. PubMed ID: 7030547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
    Manno C; Gesualdo L; D'Altri C; Rossini M; Grandaliano G; Schena FP
    J Nephrol; 2001; 14(4):248-52. PubMed ID: 11506246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP; van den Brand JA; Wetzels JF
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy.
    Okada H; Suzuki H; Konishi K; Sakaguchi H; Saruta T
    Clin Nephrol; 1992 May; 37(5):235-8. PubMed ID: 1606773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.